Lipophilic character and biological activity of drugs. II. The parabolic case.
about
Genetic activity spectra of some antischistosomal compounds, with particular emphasis on thioxanthenones and benzothiopyranoindazoles.Structure-activity relationships in nitrosamine carcinogenesis.In vivo evaluation of the radiosensitizing and cytotoxic properties of newly synthesized electron-affinic drugs.A NON-LINEAR STRUCTURE-PROPERTY MODEL FOR OCTANOL-WATER PARTITION COEFFICIENTThe challenge of predicting drug toxicity in silico.Modeling kinetics of subcellular disposition of chemicals.Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies.Is there a specific receptor for anesthetics? Contrary effects of alcohols and fatty acids on phase transition and bioluminescence of firefly luciferase.The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.Use of a physical multi-cell model to confirm theoretical predictions of biphasic structure-activity relationships [proceedings]Inhibition of Bacillus subtilis spore germination by various hydrophobic compounds: demonstration of hydrophobic character of the L-alanine receptor site.Sensitization by heat treatment of Escherichia coli K-12 cells to hydrophobic antibacterial compoundsPartitioning and lipophilicity in quantitative structure-activity relationships.The QSAR paradigm in the design of less toxic molecules.The rationale for the development of improved hypoxic cell radiosensitizers.Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency.Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs.Antimicrobial activity of n-alkyltrimethylammonium bromides: influence of specific growth rate and nutrient limitation.Prediction of partition coefficient of some 3-hydroxy pyridine-4-one derivatives using combined partial least square regression and genetic algorithm.Target-independent prediction of drug synergies using only drug lipophilicity.QSAR study of p56(lck) protein tyrosine kinase inhibitory activity of flavonoid derivatives using MLR and GA-PLS.Cytotoxicity and topoisomerase I/II inhibition activity of novel 4-aryl/alkyl-1-(piperidin-4-yl)-carbonylthiosemicarbazides and 4-benzoylthiosemicarbazides.Lipid-lowering properties of 6-benzoyl-2(3H)-benzothiazolone and structurally related compounds.Synthesis and In Vitro Antimycobacterial Activity of Novel N-Arylpiperazines Containing an Ethane-1,2-diyl Connecting Chain.Quantitative structure activity relationship for the effect of benzoic acids, cinnamic acids and benzaldehydes on Listeria monocytogenes.An experimental assessment of the Wagner-Sedman extraction theory for the intestinal absorption of antibacterial sulfonamides.Design, synthesis, in silico, and in vitro evaluation of novel pyrimidine phosphonates with cytotoxicity against breast cancer cells
P2860
Q34081288-683410FD-98C0-4FD8-BB73-C3DE2C6FE551Q36068430-064BAB86-94D1-402E-B2D3-AFDE2FCE8B3FQ36290690-A5018A38-B136-46FC-AF5C-D96CCB4420A7Q36419612-7500D654-DCC2-4D49-BBB3-A2B11C6966E5Q36575932-2F617914-5A70-4CF8-A6B8-2A60ACFD86CAQ37194304-287A572E-5806-4712-9554-2B024DC3CC4AQ38031255-4572D5D9-67CB-4033-9163-943D2B28636EQ38550955-B17E7645-820E-41AB-882A-7343C3408BFDQ38629117-112A08F4-2A0E-4E00-B69E-4A718DAD779FQ39228213-0E9CFE86-9BB1-4D93-B8BF-FD6BBFF61E71Q39628734-18707CA9-8BB1-4786-BC64-66A74F926544Q39832645-B5A8B2CD-3A3D-4DBA-AE56-F9395526417BQ39834940-AFABD8DC-5A13-4869-891A-60AEAB4DA1DAQ40203320-C0C3F5AB-C3BE-4578-B5E8-FB15DD49627AQ40544355-A30B8D8A-36C3-4B18-8596-4DBC4F41557FQ40711994-0D8A0AF7-4CB1-4D8A-AC22-FF3B7FFDCAB7Q40945559-392BC412-5B49-4917-910B-FEEA0DD92739Q41345534-7FFD6B38-8C35-4BE2-9215-B7CDF03FA754Q41470377-9D5892D6-CEFD-42D5-848A-164F51CD7101Q41775288-916F3A6A-44FA-4DD0-92F3-8804538B4B5FQ42108816-B98A34D1-0E3B-43AD-9B10-F473111EB76DQ44357747-45EEB556-697E-4B20-9A15-1B37E82D7D1FQ46891599-D0E76FF9-04B4-40C2-8966-3E2EC2A6B1FCQ47775989-8623C434-5BF7-424A-A913-99B007857653Q52308830-78ADBDE8-7A6C-4D3A-AF33-8AE62BC69716Q52760483-DCC69D8B-363B-4B5D-AD05-82CF4D01B4A2Q57458304-9C4A0C04-0EB0-472C-B806-8EFE389BCA22
P2860
Lipophilic character and biological activity of drugs. II. The parabolic case.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年学术文章
@wuu
1973年学术文章
@zh-cn
1973年学术文章
@zh-hans
1973年学术文章
@zh-my
1973年学术文章
@zh-sg
1973年學術文章
@yue
1973年學術文章
@zh
1973年學術文章
@zh-hant
name
Lipophilic character and biological activity of drugs. II. The parabolic case.
@en
Lipophilic character and biological activity of drugs. II. The parabolic case.
@nl
type
label
Lipophilic character and biological activity of drugs. II. The parabolic case.
@en
Lipophilic character and biological activity of drugs. II. The parabolic case.
@nl
prefLabel
Lipophilic character and biological activity of drugs. II. The parabolic case.
@en
Lipophilic character and biological activity of drugs. II. The parabolic case.
@nl
P356
P1476
Lipophilic character and biological activity of drugs. II. The parabolic case.
@en
P2093
P356
10.1002/JPS.2600620102
P407
P577
1973-01-01T00:00:00Z